C-SCAPE: Efficacy and Safety of 12 weeks of Grazoprevir +/- Elbasvir +/- Ribavirin in Patients with HCV GT2, 4, 5, or 6 Infection [Abstract P0771]

Brown A, Hézode C, Zuckerman E, Foster GR, Zekry A, Roberts S, et al.. C-SCAPE: Efficacy and Safety of 12 weeks of Grazoprevir +/- Elbasvir +/- Ribavirin in Patients with HCV GT2, 4, 5, or 6 Infection [Abstract P0771]. In 50th Annual Meeting of the European Association for the Study of the Liver (EASL). Vienna, Austria; 2015.

Publication Type:

Conference Paper

Source:

50th Annual Meeting of the European Association for the Study of the Liver (EASL), Number Abstract P0771, Vienna, Austria (2015)
Top